ArticleThe Journal of experimental medicine2002
DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
Alex I Zaika et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
146 papers cite itlatest 60 shown
this paperpooled itcites it